✦ LIBER ✦

Efficacy and safety of 90Y ibritumomab tiuxetan (zevalin) radioimmunotherapy for non-Hodgkin’s lymphoma

✍ Scribed by Thomas E Witzig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of radioimmunotherap

✍ Hossein Borghaei; Russell J Schilder 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Safety and efficacy of external beam rad

✍ Terry E. Justice; James A. Martenson; Gregory A. Wiseman; Thomas E. Witzig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Use of 90Y-ibritumomab tiuxetan in non-H

✍ Robert Marcus 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Yttrium 90 ibritumomab tiuxetan radioimm

✍ Leo I Gordon; Thomas E Witzig; Greg A Wiseman; Ian W Flinn; Stewart S Spies; Dan 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Radioimmunotherapy in Non-Hodgkin's Lymp

✍ Evens, Andrew M.; Gordon, Leo I. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB

Phase I/II90Y-Zevalin (yttrium-90 ibritu

✍ Gregory A. Wiseman; Christine A. White; Michael Stabin; William L. Dunn; William 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 166 KB